KOFOL RUB

Indications

• Topical analgesic for muscle and joint pain
• Relief of minor aches and pains
• Treatment of superficial skin irritations

Dosage

Adults: For topical use, apply to the affected area not more than 3 to 4 times daily. Refer to specific product instructions for concentration and formulation.

Mechanism of action

Camphor activates the transient receptor potential (TRP) channel TRPV3 and has been shown to also activate TRPV1 at higher concentrations. This activation is enhanced under conditions that mimic inflammation, as it is linked to phospholipase C-coupled receptor stimulation. Although camphor activates TRPV1 less effectively than capsaicin, it desensitizes TRPV1 more rapidly and completely, contributing to its analgesic effects. Camphor's interaction with these receptors leads to a sensation of warmth and relief from pain, making it effective in topical applications.

Pharmacodynamics

Camphor exhibits local analgesic and anti-inflammatory effects when applied topically. It produces a warming sensation due to its action on sensory neurons, which can help to alleviate pain. The activation of TRPV1 and TRPV3 channels results in a complex modulation of sensory nerve signaling, leading to both excitatory and inhibitory effects on pain perception. Its ability to desensitize TRPV1 may contribute to the reduction of pain sensation over time with repeated application.

Pharmacokinetics

When applied topically, camphor is absorbed through the skin, though its systemic absorption is minimal. It is metabolized in the liver, and its metabolites are excreted primarily in urine. The onset of action is typically rapid due to its local effects, while the duration of action can vary based on the formulation and concentration used. Care should be taken to avoid excessive application to prevent potential systemic effects.

Pregnancy

Camphor should be avoided during pregnancy due to potential risks to the fetus.

Breast-feeding

Camphor is excreted in breast milk and should be used with caution while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight and out of reach of children.

Formulations

• Topical ointments
• Liniments
• Balms

Indications

• Dyspepsia
• Flatulence
• Bloating
• Loss of appetite
• Digestive disorders

Dosage

Children: Refer to established guidelines for specific dosing recommendations, as the dosage may vary based on age, weight, and indication.

Adults: Refer to established guidelines for specific dosing recommendations, as the dosage may vary based on the preparation and indication.

Mechanism of action

The active components of carum, particularly carvone, exert their effects primarily through modulation of gastrointestinal motility and secretion. Carvone may stimulate digestive enzymes and promote smooth muscle relaxation, helping to alleviate symptoms of bloating and cramping. Additionally, the essential oils in carum may possess antimicrobial properties, contributing to gastrointestinal health.

Pharmacodynamics

Carum exhibits several pharmacodynamic properties, including carminative, antimicrobial, and digestive stimulant effects. It is believed to enhance gastric secretions and promote smooth muscle activity in the gastrointestinal tract, leading to improved digestion and reduced flatulence. The anti-inflammatory properties of its essential oils may also contribute to its therapeutic profile.

Pharmacokinetics

The pharmacokinetics of carum, particularly its essential oils, involve absorption through the gastrointestinal tract following ingestion. The active compounds are distributed throughout the body, with a significant concentration in the liver and gastrointestinal tissues. The metabolism of carvone occurs primarily in the liver, and excretion is mainly via urine. The bioavailability of these compounds can vary based on the preparation and individual metabolism.

Pregnancy

Safety during pregnancy has not been established. Consult healthcare professionals before use.

Breast-feeding

Consult healthcare professionals before use during breastfeeding.

Storage

Store in a cool, dry place away from direct light.

Indications

• Gastrointestinal infections
• Irritable bowel syndrome
• Diarrhea
• Inflammatory bowel disease
• Metabolic syndrome
• Type 2 diabetes

Dosage

Children: Refer to professional guidelines for specific dosing, considering the condition being treated and individual patient factors.

Adults: Refer to professional guidelines for specific dosing, considering the condition being treated and individual patient factors.

Mechanism of action

The primary active alkaloid, berberine, exerts its effects through several mechanisms. It activates adenosine monophosphate-activated protein kinase (AMPK), which plays a crucial role in cellular energy homeostasis. Berberine also inhibits various pathogens by disrupting their cell membranes and inhibiting oxidative stress. It has been shown to modulate glucose metabolism, lipid metabolism, and has anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines.

Pharmacodynamics

Copticum demonstrates a broad range of pharmacodynamic effects including antimicrobial activity against bacteria, fungi, and protozoa. Its anti-inflammatory properties help in reducing inflammation markers in various conditions. Furthermore, it influences metabolic pathways, leading to improved glucose and lipid profiles, making it potentially beneficial for metabolic syndrome and diabetes management.

Pharmacokinetics

After oral administration, berberine is poorly absorbed in the gastrointestinal tract, leading to low systemic bioavailability. It undergoes extensive first-pass metabolism in the liver. However, it can accumulate in tissues, particularly in the intestines and liver. The elimination half-life of berberine is approximately 4 to 6 hours, and it is primarily excreted via the bile and urine. Its pharmacokinetic properties can be influenced by factors such as dietary components and concurrent medications.

Pregnancy

The safety of copticum during pregnancy has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Copticum is not recommended during breastfeeding, as its effects on nursing infants are unknown.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Respiratory infections
• Cough and cold symptoms
• Sinusitis
• Bronchitis
• Muscle pain and inflammation

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil in children, as it varies based on formulation and indication.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil, as it varies based on formulation and indication.

Mechanism of action

Eucalyptus oil contains compounds such as eucalyptol (1,8-cineole) that exhibit antimicrobial properties. It acts on the respiratory system by promoting bronchodilation and reducing mucus production. The oil also has a cooling effect, which can provide relief from symptoms of respiratory distress. Additionally, the oil's anti-inflammatory properties help decrease inflammation in the airways.

Pharmacodynamics

The primary active ingredient in eucalyptus oil, eucalyptol, interacts with the body's inflammatory response and can modulate the activity of neurotransmitters involved in pain signaling. It may enhance mucociliary clearance in the respiratory tract, facilitating the expulsion of mucus and pathogens. The analgesic effects can help relieve discomfort associated with respiratory infections.

Pharmacokinetics

Eucalyptus oil is typically administered via inhalation or topical application. When inhaled, components like eucalyptol are absorbed through the mucous membranes of the respiratory tract and rapidly distributed throughout the body. The oil is metabolized primarily in the liver, and its metabolites are excreted in urine. The half-life of eucalyptol varies but is generally short, necessitating frequent dosing for sustained effects.

Adverse effects

• Allergic reactions
• Skin irritation
• Nausea
• Vomiting
• Diarrhea
• Dizziness

Interactions

• May interact with anticoagulants, potentially increasing bleeding risk
• May enhance the effects of other medications that cause sedation

Precautions

• Use with caution in individuals with asthma or other respiratory conditions
• Avoid use in young children without medical supervision
• Eucalyptus oil should not be ingested in large quantities due to toxicity

Pregnancy

Eucalyptus oil is generally considered unsafe in pregnancy due to potential toxicity and should be avoided unless prescribed by a healthcare professional.

Breast-feeding

Caution is advised when using eucalyptus during breastfeeding, as it may pass into breast milk and could affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Eucalyptus oil (topical, inhalation, or oral preparations)
• Eucalyptus leaves (dried for teas or extracts)

Indications

• Osteoarthritis
• Rheumatoid arthritis
• Asthma
• Ulcerative colitis
• Crohn's disease
• Inflammatory bowel disease
• Anxiety
• Stress-related disorders

Dosage

Children: Paediatric dosing should be determined by a healthcare professional based on the child's age, weight, and specific condition.

Adults: Dosage for adults varies based on the condition being treated and the formulation used. It is advisable to follow product-specific guidelines or consult a healthcare professional for dosing recommendations.

Mechanism of action

The primary mechanism of action of fragrans involves the inhibition of pro-inflammatory mediators and enzymes such as 5-lipoxygenase, which plays a role in the production of leukotrienes. Boswellic acids, the main active components, inhibit the synthesis of these inflammatory mediators, thereby reducing inflammation and pain. Additionally, these compounds may modulate immune responses and have antioxidant effects.

Pharmacodynamics

Fragrans exhibits anti-inflammatory and analgesic effects, making it beneficial in the management of inflammatory conditions such as arthritis and asthma. The anti-inflammatory activity is thought to result from its ability to inhibit leukotriene biosynthesis. Furthermore, the resin may have mood-enhancing properties when used in aromatherapy, potentially due to its effects on the central nervous system and limbic system.

Pharmacokinetics

Fragrans is typically administered through oral, topical, or inhalation routes. Following administration, the active components are absorbed into the bloodstream, where they exert systemic effects. The bioavailability of boswellic acids can vary depending on the formulation and route of administration. Metabolism primarily occurs in the liver, with excretion primarily via the kidneys. The pharmacokinetic profile can be influenced by factors such as the presence of food and specific formulations.

Pregnancy

Insufficient data on safety in pregnancy. Caution is advised.

Breast-feeding

Limited information available. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Respiratory tract infections
• Cough relief
• Bronchitis
• Sinusitis
• Topical pain relief

Dosage

Children: Refer to product-specific guidelines for dosing in children, as it is essential to consider age and weight.

Adults: Refer to product-specific guidelines for dosing, as it can vary depending on formulation and indication.

Mechanism of action

Eucalyptol acts as an expectorant and has mucolytic properties, helping to clear mucus from the airways. It also exhibits anti-inflammatory effects by inhibiting pro-inflammatory mediators and has mild analgesic properties. Eucalyptol may modulate the immune response, enhancing respiratory function and reducing cough reflex.

Pharmacodynamics

The pharmacodynamics of globulus are characterized by its ability to alleviate symptoms of respiratory tract infections, including cough and congestion. The compound eucalyptol promotes bronchodilation and enhances mucosal clearance, contributing to improved respiratory function. Additionally, its antiseptic properties help combat infections in the respiratory tract.

Pharmacokinetics

Eucalyptol is rapidly absorbed when inhaled or applied topically. It is metabolized primarily in the liver and eliminated via the kidneys. The half-life of eucalyptol varies but is generally short, necessitating frequent dosing for sustained effects. Its bioavailability may be influenced by the route of administration, with inhalation providing more immediate effects.

Pregnancy

Consult healthcare provider before use. Limited data on safety.

Breast-feeding

Consult healthcare provider before use. Limited data on safety.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Male infertility
• Low libido
• Erectile dysfunction
• Fatigue
• Physical performance enhancement
• Stress relief

Dosage

Adults: Refer to specific product guidelines, as dosing can vary based on formulation and intended use. Generally, doses range from 200 mg to 400 mg of standardized extract per day.

Mechanism of action

The primary mechanism of action of Longifolia involves the stimulation of testosterone production through the modulation of luteinizing hormone (LH) release. It may also inhibit the conversion of testosterone to estrogen, thereby increasing serum testosterone levels. Additionally, Longifolia may exert adaptogenic effects, helping the body to respond to stress and improve physical performance.

Pharmacodynamics

Longifolia demonstrates various pharmacodynamic properties, including potential aphrodisiac effects, anti-estrogenic activity, and enhancement of physical endurance. The herb may also exhibit antioxidant properties, contributing to improved overall health. These effects are primarily attributed to its active compounds, such as quassinoids, which are believed to influence hormonal balance and promote energy levels.

Pharmacokinetics

The pharmacokinetics of Longifolia are not well-documented in terms of absorption, distribution, metabolism, and excretion. However, it is generally considered that the active compounds are absorbed after oral administration, with bioavailability influenced by factors such as formulation and dosage. The elimination half-life remains unclear, necessitating further research to establish comprehensive pharmacokinetic profiles.

Pregnancy

There is insufficient reliable information regarding the safety of longifolia during pregnancy. It is recommended to avoid use unless specifically advised by a healthcare professional.

Breast-feeding

Due to a lack of data on the excretion of longifolia in breast milk, it is advisable to exercise caution and consult a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Digestive issues
• Nausea
• Headaches
• Muscle pain
• Respiratory conditions such as cough and nasal congestion

Dosage

Children: Refer to specific formulations and product guidelines for pediatric dosing, as formulations may vary and should be used with caution in children.

Adults: Refer to specific formulations and product guidelines for dosing, as mentha is available in various forms including teas, extracts, and topical applications.

Mechanism of action

Mentha species contain essential oils, primarily menthol and menthone, which exert their effects through several mechanisms. Menthol acts as a competitive antagonist of the transient receptor potential cation channel subfamily M member 8 (TRPM8), which is involved in the sensation of cold. This interaction provides a cooling sensation and can help alleviate pain. Additionally, menthol has been shown to have antispasmodic effects on smooth muscle, which may contribute to its use in digestive disorders.

Pharmacodynamics

The pharmacodynamic properties of mentha are attributed to its active constituents, particularly menthol. It exhibits analgesic, anti-inflammatory, and antispasmodic effects. The cooling sensation produced by menthol can also trigger the release of endorphins, which may enhance its analgesic properties. Furthermore, menthol can increase local blood flow, which aids in the relief of muscle tension and pain.

Pharmacokinetics

Mentha's pharmacokinetics can vary based on the method of administration (oral, topical, or inhalation). When ingested, menthol is rapidly absorbed in the gastrointestinal tract and metabolized in the liver. Peak plasma concentrations are usually achieved within 30 to 60 minutes. The elimination half-life of menthol is approximately 2 to 4 hours. Topically applied menthol may provide localized effects with minimal systemic absorption, reducing the risk of systemic side effects.

Adverse effects

• Allergic reactions
• Heartburn
• Nausea
• Vomiting
• Skin irritation

Interactions

• May interact with anticoagulants
• May affect the absorption of certain medications due to its effects on gastrointestinal motility

Precautions

• Use with caution in individuals with gastroesophageal reflux disease (GERD)
• Caution in patients with liver disease
• Avoid use in infants and young children due to potential respiratory issues

Pregnancy

Mentha is generally considered safe in food amounts, but high doses should be avoided due to potential effects on uterine contractions.

Breast-feeding

Mentha is likely safe in food amounts during breastfeeding, but high doses should be avoided due to potential effects on milk supply and infant health.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Tea
• Extracts
• Capsules

Indications

• Digestive disorders
• Nausea
• Pain relief
• Anti-inflammatory conditions
• Mood enhancement

Dosage

Children: Pediatric dosing information is not well established. It is recommended to consult healthcare professionals for appropriate dosing based on age

Adults: Dosage can vary widely based on the form of administration and the intended effect. Generally, culinary uses involve small amounts of ground nutmeg. For medicinal purposes, it is advisable to consult specific guidelines or healthcare professionals.

Mechanism of action

The primary active compounds in Myristica, particularly myristicin, are thought to exert their effects through modulation of neurotransmitter systems, particularly in the central nervous system. Myristicin may inhibit the enzyme monoamine oxidase, leading to increased levels of neurotransmitters such as serotonin and dopamine. This mechanism may contribute to its psychoactive effects, while other compounds like eugenol exhibit anti-inflammatory and analgesic properties through inhibition of cyclooxygenase enzymes.

Pharmacodynamics

Myristica exhibits various pharmacodynamic effects, including anti-inflammatory, analgesic, and potential psychoactive actions. The compounds found in nutmeg may influence mood and cognition, though these effects are dose-dependent and can lead to toxicity at higher doses. Myristica may also enhance digestive processes and reduce gastrointestinal discomfort due to its carminative properties.

Pharmacokinetics

The pharmacokinetics of Myristica and its active components are not extensively studied, but it is known that the bioavailability of myristicin and other compounds can be affected by their metabolic pathways. After ingestion, these compounds undergo hepatic metabolism, primarily through cytochrome P450 enzymes. The half-life and elimination pathways are not well-defined, and effects can vary significantly among individuals due to differences in metabolism and sensitivity to the psychoactive properties.

Pregnancy

Myristica is not well-studied in pregnant women; caution is advised.

Breast-feeding

There is insufficient data on the safety of Myristica during breastfeeding; it is recommended to consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Nausea and vomiting (including motion sickness and postoperative nausea)
• Digestive disorders (such as dyspepsia)
• Inflammatory conditions (like osteoarthritis and rheumatoid arthritis)
• Respiratory conditions (such as cough and bronchitis)
• Menstrual pain

Dosage

Children: Refer to established clinical guidelines and the BNF for Children, as specific dosing should be tailored to the child's age and condition.

Adults: Refer to established clinical guidelines, as specific dosing can vary depending on the formulation and indication.

Mechanism of action

The active components of ginger, particularly gingerol, exert their effects through various pathways, including the inhibition of pro-inflammatory cytokines and the modulation of several receptors, such as the TRPV1 and 5-HT3 receptors. Ginger also enhances gastrointestinal motility and may influence the absorption and metabolism of drugs by affecting cytochrome P450 enzymes.

Pharmacodynamics

Ginger shows antiemetic, anti-inflammatory, and analgesic properties. It can reduce nausea and vomiting, making it effective in conditions such as motion sickness and chemotherapy-induced nausea. The anti-inflammatory effects are attributed to the inhibition of cyclooxygenase (COX) enzymes and the reduction of inflammatory mediators, which can help alleviate pain and swelling in various inflammatory disorders.

Pharmacokinetics

Ginger is absorbed in the gastrointestinal tract, with its bioactive compounds undergoing extensive metabolism. The systemic availability of gingerol and its metabolites can vary based on the formulation and route of administration. The elimination half-life of ginger compounds is not well established, but they are generally excreted through urine and feces. The onset of action may vary, typically within 30 minutes to a few hours, depending on the condition being treated.

Pregnancy

Consult with a healthcare provider before use, as safety during pregnancy has not been established.

Breast-feeding

Consult with a healthcare provider before use, as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Cardiovascular support
• Antioxidant therapy
• Anti-inflammatory treatment
• Management of chronic venous insufficiency
• Support for skin health

Dosage

Children: Refer to specific product guidelines for dosing, as it can vary depending on the formulation and intended use.

Adults: Refer to specific product guidelines for dosing, as it can vary depending on the formulation and intended use.

Mechanism of action

The active compounds in pine extracts, such as proanthocyanidins, exhibit antioxidant activity by scavenging free radicals and modulating oxidative stress pathways. These compounds also enhance endothelial function, improve blood circulation, and may downregulate inflammatory mediators, thereby contributing to their therapeutic effects.

Pharmacodynamics

Pine extracts demonstrate a variety of pharmacological effects, including vasodilation, anti-inflammatory actions, and improved microcirculation. The antioxidant properties help in protecting cells from damage caused by oxidative stress, which is implicated in numerous chronic diseases.

Pharmacokinetics

Pine extracts are generally well absorbed when taken orally, with peak plasma concentrations occurring within several hours. The metabolism of its active constituents primarily occurs in the liver, where they undergo various transformations before being excreted. The elimination half-life can vary depending on the specific compound and individual factors such as age and health status.

Contra-indications

• Hypersensitivity to pinus or any of its components
• Active bleeding disorders
• Severe liver disease

Adverse effects

• Gastrointestinal disturbances
• Allergic reactions
• Headache
• Dizziness
• Skin rashes

Interactions

• Anticoagulants may have increased effects
• Caution with other herbal supplements that affect coagulation

Precautions

• Use with caution in patients with a history of allergies
• Monitor for bleeding risk in patients taking anticoagulants
• Consult with a healthcare professional before use in pregnant or breastfeeding women

Pregnancy

There is insufficient data on the safety of pinus during pregnancy. It is advisable to avoid use unless clearly needed.

Breast-feeding

It is unknown if pinus is excreted in human milk. Caution is advised when using in breastfeeding women.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Oral capsules
• Liquid extracts
• Topical preparations

Indications

• Allergic rhinitis
• Urticaria
• Allergic conjunctivitis
• Anaphylactic reactions (as adjunctive therapy)

Dosage

Children: Refer to the specific prescribing information or guidelines for paediatric dosing.

Adults: Refer to the specific prescribing information or guidelines for adult dosing.

Mechanism of action

Piperata acts as a competitive antagonist of histamine at the H1 receptor. By binding to these receptors, it prevents histamine from exerting its effects, which include vasodilation, increased vascular permeability, and stimulation of sensory nerves. This mechanism is crucial in mitigating the physiological responses associated with allergic reactions.

Pharmacodynamics

The pharmacodynamic effects of piperata include the reduction of allergic symptoms through its antihistaminic properties. It also exhibits anticholinergic activity, which can contribute to its efficacy in reducing secretions and causing sedation. The onset of action typically occurs within 1 to 2 hours after administration, and the duration of action can last several hours, depending on the formulation and individual patient factors.

Pharmacokinetics

Piperata is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1 to 2 hours post-ingestion. It is metabolized primarily in the liver through cytochrome P450 enzymes, and its metabolites are excreted primarily via the urine. The elimination half-life is generally around 6 to 12 hours, although this can vary based on patient-specific factors, including age and liver function.

Pregnancy

Piperata is generally not recommended during pregnancy due to potential risks to the fetus and lack of sufficient safety data.

Breast-feeding

Piperata is not advised during breastfeeding as it may be excreted in breast milk and could affect the nursing infant.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Mechanism of action

Camphor is a naturally occurring compound that is used as a major active ingredient of balms and liniments supplied as topical analgesics. ... Capsaicin and menthol, two other topically applied agents widely used for similar purposes, are known to excite and desensitize sensory nerves by acting on two members of transient receptor potential (TRP) channel superfamily: heat-sensitive TRP vanilloid subtype 1 (TRPV1) and cold-sensitive TRP channel M8, respectively. Camphor has recently been shown to activate TRPV3, and here /investigators/ show that camphor also activates heterologously expressed TRPV1, requiring higher concentrations than capsaicin. Activation was enhanced by phospholipase C-coupled receptor stimulation mimicking inflamed conditions. Similar camphor-activated TRPV1-like currents were observed in isolated rat DRG neurons and were strongly potentiated after activation of protein kinase C with phorbol-12-myristate-13-acetate. Camphor activation of rat TRPV1 was mediated by distinct channel regions from capsaicin, as indicated by camphor activation in the presence of the competitive inhibitor capsazepine and in a capsaicin-insensitive point mutant. Camphor did not activate the capsaicin-insensitive chicken TRPV1. TRPV1 desensitization is believed to contribute to the analgesic actions of capsaicin. /The authors/ found that, although camphor activates TRPV1 less effectively, camphor application desensitized TRPV1 more rapidly and completely than capsaicin. Conversely, TRPV3 current sensitized after repeated camphor applications, which is inconsistent with the analgesic role of camphor. /Investigators/ also found that camphor inhibited several other related TRP channels, including ankyrin-repeat TRP 1 (TRPA1). The camphor-induced desensitization of TRPV1 and block of TRPA1 may underlie the analgesic effects of camphor.